Currently the Enterprise Value (EV) is not available for Standard BioTools.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 1.45,
with a Debt / Equity ratio of 1.11.
1.45
1.03
1.11
-2.37
-1.83
-15.65
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$212.33K
$-96.32K
615
0.47
2.94
Taxes
-4.42M
6.95%
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 1.14, so Standard BioTools's
price volatility has been higher than the market average.
1.14
n/a
3.56
n/a
50.89
956,988
Income Statement
In the last 12 months, Standard BioTools had revenue of 130.58M
and earned -59.24M
in profits. Earnings per share was -0.78.